Header cover image

Investing Ideas
/
Chinese Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Chinese Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Results

6

0 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

6 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	002422 Sichuan Kelun Pharmaceutical	CN¥30.60	-10.1%	14.0%	CN¥48.5b	CN¥43.03	PE16.4x	E11.4%	1.7%
	002773 Chengdu Kanghong Pharmaceutical Group	CN¥19.57	-1.2%	11.5%	CN¥18.0b	n/a	PE15.1x	E13.4%	1.9%
	600420 Shanghai Shyndec Pharmaceutical	CN¥12.47	-2.0%	24.0%	CN¥16.7b	CN¥19.24	PE15.5x	E16.0%	1.6%
	000403 Pacific Shuanglin Bio-pharmacy	CN¥22.66	-3.7%	-9.3%	CN¥16.6b	CN¥32.27	PE20x	E12.7%	0.9%
	600285 Henan Lingrui Pharmaceutical	CN¥21.89	-3.1%	32.8%	CN¥12.3b	CN¥30.05	PE18.2x	E16.1%	3.7%
	603439 Guizhou Sanli PharmaceuticalLtd	CN¥14.02	-3.2%	-26.1%	CN¥5.6b	n/a	PE17.1x	E21.4%	1.4%

Page 1 of 1